2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 000 | - | - | ||
| 2 280 | - | - | ||
| 3 000 | - | - | ||
| 1 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·47 min sittenWhere did all the news from investornytt go?? Don't they write about bad news in this stock?
·2 min sittenTeigland only writes about possible upsides - and has probably sold his CRNA shares. https://www.finansavisen.no/finans/2025/12/01/8311398/finanstilsynets-kjempebot-til-espen-teigland-apenbart-at-din-plan-var-i-strid-med-rettferdighet
·52 min sittenI am completely new to stocks and I'm wondering if you experienced people here use any other apps/tools to keep track? 😀
·19 min sittenQuartr is a fantastic app for keeping an eye on upcoming earnings reports and conference calls in the companies one invests in, it consolidates it well. Yahoo finance is quite excellent for general market news. I like to use US calendee to keep an eye on the release of key figures, but that is less important, it's more if I am in the process of making an investment, then I might wait if an important day is just around the corner
·53 min sittenOslo, Norway April 15, 2026 – The Board of Directors of Circio Holding ASA today approved the company's remuneration report and annual report, including the financial statements for 2025, which are to be approved by the company's ordinary general meeting (general meeting) to be held on May 8, 2026. The remuneration report for 2025 and the annual report for 2025 (including the auditor's report) and the version of the annual report in the European Single Electronic Format (ESEF) are attached to this press release and will be made available on the company's website.- ·1 t sittenShort answer: it's most likely hype + speculation, not that "3 kr tomorrow" is fundamentally certain. Here's what actually drives such claims around Circio (CRNA) now: ⸻ 📈 1. People trade momentum (not value) When a stock has gone up extremely much (talking several hundred–thousand %), there often comes a phase where people just buy because it's going up. • "More buyers than sellers" → the price is pushed up  • Many set arbitrary targets like 2 kr, 3 kr, 5 kr etc. 👉 That doesn't mean that 3 kr is the "correct value" – just a psychological level people talk about. ⸻ 🧪 2. Biotech = expectations, not revenues Circio is a preclinical biotech company: • Little/no revenues • Value is driven by hope for future technology (RNA platform) • Potential "triggers" like conferences, data, collaborations  👉 Therefore, the price can move a lot on rumors and expectations. ⸻ 🚀 3. The narrative: "can be acquired" Many buy because they believe: • Big Pharma can buy the company • Similar companies have been sold expensively • "Someone knows something" (classic stock market rumor) 👉 This is not confirmed, just speculation. ⸻ ⚠️ 4. Extreme risk (important) This is the part many ignore: • The stock has gone up 800–2000%+ in a short time  • Weak fundamental figures • Can fall sharply as fast as it rose 👉 Typical "hype-cycle": up → euphoria → FOMO → dump ⸻ 🧠 The reality behind "3 kr tomorrow" When people say that, it actually means: • "I believe/hope it continues to rise" • or trying to create FOMO in others Not: • analysis • guarantee • actual price target based on figures ⸻ ✅ Conclusion: People talk about 3 kr because: • momentum + hype • expectations for news • speculation about acquisition ❗ But it is a high-risk trading stock, not a safe investment.·19 min sittenHehe, yeah… it's always full of “experts” in comment sections and forums 😶🌫️ Often there's a good mix of people who actually know something, and those who just sound very confident. The best trick is really to be a bit selective: If someone explains why something is correct, refers to sources, or is open to nuances, that's usually a better sign than dogmatic claims without justification. What kind of forum are you talking about? The same pattern repeats a bit everywhere, but some places are worse than others 😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·47 min sittenWhere did all the news from investornytt go?? Don't they write about bad news in this stock?·2 min sittenTeigland only writes about possible upsides - and has probably sold his CRNA shares. https://www.finansavisen.no/finans/2025/12/01/8311398/finanstilsynets-kjempebot-til-espen-teigland-apenbart-at-din-plan-var-i-strid-med-rettferdighet
- ·52 min sittenI am completely new to stocks and I'm wondering if you experienced people here use any other apps/tools to keep track? 😀·19 min sittenQuartr is a fantastic app for keeping an eye on upcoming earnings reports and conference calls in the companies one invests in, it consolidates it well. Yahoo finance is quite excellent for general market news. I like to use US calendee to keep an eye on the release of key figures, but that is less important, it's more if I am in the process of making an investment, then I might wait if an important day is just around the corner
- ·53 min sittenOslo, Norway April 15, 2026 – The Board of Directors of Circio Holding ASA today approved the company's remuneration report and annual report, including the financial statements for 2025, which are to be approved by the company's ordinary general meeting (general meeting) to be held on May 8, 2026. The remuneration report for 2025 and the annual report for 2025 (including the auditor's report) and the version of the annual report in the European Single Electronic Format (ESEF) are attached to this press release and will be made available on the company's website.
- ·1 t sittenShort answer: it's most likely hype + speculation, not that "3 kr tomorrow" is fundamentally certain. Here's what actually drives such claims around Circio (CRNA) now: ⸻ 📈 1. People trade momentum (not value) When a stock has gone up extremely much (talking several hundred–thousand %), there often comes a phase where people just buy because it's going up. • "More buyers than sellers" → the price is pushed up  • Many set arbitrary targets like 2 kr, 3 kr, 5 kr etc. 👉 That doesn't mean that 3 kr is the "correct value" – just a psychological level people talk about. ⸻ 🧪 2. Biotech = expectations, not revenues Circio is a preclinical biotech company: • Little/no revenues • Value is driven by hope for future technology (RNA platform) • Potential "triggers" like conferences, data, collaborations  👉 Therefore, the price can move a lot on rumors and expectations. ⸻ 🚀 3. The narrative: "can be acquired" Many buy because they believe: • Big Pharma can buy the company • Similar companies have been sold expensively • "Someone knows something" (classic stock market rumor) 👉 This is not confirmed, just speculation. ⸻ ⚠️ 4. Extreme risk (important) This is the part many ignore: • The stock has gone up 800–2000%+ in a short time  • Weak fundamental figures • Can fall sharply as fast as it rose 👉 Typical "hype-cycle": up → euphoria → FOMO → dump ⸻ 🧠 The reality behind "3 kr tomorrow" When people say that, it actually means: • "I believe/hope it continues to rise" • or trying to create FOMO in others Not: • analysis • guarantee • actual price target based on figures ⸻ ✅ Conclusion: People talk about 3 kr because: • momentum + hype • expectations for news • speculation about acquisition ❗ But it is a high-risk trading stock, not a safe investment.·19 min sittenHehe, yeah… it's always full of “experts” in comment sections and forums 😶🌫️ Often there's a good mix of people who actually know something, and those who just sound very confident. The best trick is really to be a bit selective: If someone explains why something is correct, refers to sources, or is open to nuances, that's usually a better sign than dogmatic claims without justification. What kind of forum are you talking about? The same pattern repeats a bit everywhere, but some places are worse than others 😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 000 | - | - | ||
| 2 280 | - | - | ||
| 3 000 | - | - | ||
| 1 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·47 min sittenWhere did all the news from investornytt go?? Don't they write about bad news in this stock?·2 min sittenTeigland only writes about possible upsides - and has probably sold his CRNA shares. https://www.finansavisen.no/finans/2025/12/01/8311398/finanstilsynets-kjempebot-til-espen-teigland-apenbart-at-din-plan-var-i-strid-med-rettferdighet
- ·52 min sittenI am completely new to stocks and I'm wondering if you experienced people here use any other apps/tools to keep track? 😀·19 min sittenQuartr is a fantastic app for keeping an eye on upcoming earnings reports and conference calls in the companies one invests in, it consolidates it well. Yahoo finance is quite excellent for general market news. I like to use US calendee to keep an eye on the release of key figures, but that is less important, it's more if I am in the process of making an investment, then I might wait if an important day is just around the corner
- ·53 min sittenOslo, Norway April 15, 2026 – The Board of Directors of Circio Holding ASA today approved the company's remuneration report and annual report, including the financial statements for 2025, which are to be approved by the company's ordinary general meeting (general meeting) to be held on May 8, 2026. The remuneration report for 2025 and the annual report for 2025 (including the auditor's report) and the version of the annual report in the European Single Electronic Format (ESEF) are attached to this press release and will be made available on the company's website.
- ·1 t sittenShort answer: it's most likely hype + speculation, not that "3 kr tomorrow" is fundamentally certain. Here's what actually drives such claims around Circio (CRNA) now: ⸻ 📈 1. People trade momentum (not value) When a stock has gone up extremely much (talking several hundred–thousand %), there often comes a phase where people just buy because it's going up. • "More buyers than sellers" → the price is pushed up  • Many set arbitrary targets like 2 kr, 3 kr, 5 kr etc. 👉 That doesn't mean that 3 kr is the "correct value" – just a psychological level people talk about. ⸻ 🧪 2. Biotech = expectations, not revenues Circio is a preclinical biotech company: • Little/no revenues • Value is driven by hope for future technology (RNA platform) • Potential "triggers" like conferences, data, collaborations  👉 Therefore, the price can move a lot on rumors and expectations. ⸻ 🚀 3. The narrative: "can be acquired" Many buy because they believe: • Big Pharma can buy the company • Similar companies have been sold expensively • "Someone knows something" (classic stock market rumor) 👉 This is not confirmed, just speculation. ⸻ ⚠️ 4. Extreme risk (important) This is the part many ignore: • The stock has gone up 800–2000%+ in a short time  • Weak fundamental figures • Can fall sharply as fast as it rose 👉 Typical "hype-cycle": up → euphoria → FOMO → dump ⸻ 🧠 The reality behind "3 kr tomorrow" When people say that, it actually means: • "I believe/hope it continues to rise" • or trying to create FOMO in others Not: • analysis • guarantee • actual price target based on figures ⸻ ✅ Conclusion: People talk about 3 kr because: • momentum + hype • expectations for news • speculation about acquisition ❗ But it is a high-risk trading stock, not a safe investment.·19 min sittenHehe, yeah… it's always full of “experts” in comment sections and forums 😶🌫️ Often there's a good mix of people who actually know something, and those who just sound very confident. The best trick is really to be a bit selective: If someone explains why something is correct, refers to sources, or is open to nuances, that's usually a better sign than dogmatic claims without justification. What kind of forum are you talking about? The same pattern repeats a bit everywhere, but some places are worse than others 😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 000 | - | - | ||
| 2 280 | - | - | ||
| 3 000 | - | - | ||
| 1 | - | - | ||
| 100 | - | - |
Välittäjätilasto
Dataa ei löytynyt